Sabrina Aït Amiri

Title: Sabrina Aït Amiri: Innovator in Neurodegenerative Disease Treatment

Introduction

Sabrina Aït Amiri is a prominent inventor based in Montreuil, France. She has made significant contributions to the field of medical research, particularly in the treatment of neurodegenerative and inflammatory diseases. Her innovative work has led to the development of valuable compounds that exhibit kallikrein inhibitory activity.

Latest Patents

Sabrina Aït Amiri holds 1 patent for her invention titled "Compounds and compositions for the treatment of neurodegenerative and inflammatory diseases." This invention relates to compounds that demonstrate kallikrein inhibitory activity and compositions that utilize these compounds for treating diseases where kallikrein activity is dysregulated. Her work is particularly relevant for addressing neurodegenerative and inflammatory conditions.

Career Highlights

Throughout her career, Sabrina has been associated with esteemed institutions such as Sorbonne Université and the Centre National de la Recherche Scientifique. Her research has focused on developing therapeutic solutions that can significantly impact patient care in the realm of neurodegenerative diseases.

Collaborations

Sabrina has collaborated with notable colleagues, including Chahrazade El Amri and Feryel Soualmia. These partnerships have enriched her research and contributed to the advancement of her innovative projects.

Conclusion

Sabrina Aït Amiri is a trailblazer in the field of neurodegenerative disease treatment, with her patented inventions paving the way for future advancements in medical science. Her dedication to research and collaboration continues to inspire innovation in the healthcare sector.